Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin R Pollak

Showing results (121-130 of 167) with videos related to

Pageof 17
Sort By:
Kidney International|June 29, 2016
Mice with mutant Inf2 show impaired podocyte and slit diaphragm integrity in response to protamine-induced kidney injuryBalajikarthick Subramanian, Hua Sun, Paul Yan, et al.
Journal of the American Society of Nephrology : JASN|November 16, 2013
Plasma apolipoprotein L1 levels do not correlate with CKDLeslie A Bruggeman, John F O'Toole, Michael D Ross, et al.
Nature|December 31, 2005
Stem cell engraftment at the endosteal niche is specified by the calcium-sensing receptorGregor B Adams, Karissa T Chabner, Ian R Alley, et al.
Kidney360|September 21, 2022
The KIDNEYCODE Program: Diagnostic Yield and Clinical Features of Individuals with CKDKenneth V Lieberman, Alexander R Chang, Geoffrey A Block, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 25, 2015
APOL1 kidney disease risk variants cause cytotoxicity by depleting cellular potassium and inducing stress-activated protein kinasesOpeyemi A Olabisi, Jia-Yue Zhang, Lynn VerPlank, et al.
Cardiorenal Medicine|June 15, 2017
Apolipoprotein L1 Genetic Variants Are Associated with Chronic Kidney Disease but Not with Cardiovascular Disease in a Population Referred for Cardiac CatheterizationHanghang Wang, Patrick H Pun, Lydia Kwee, et al.
Journal of the American Society of Nephrology : JASN|March 2, 2022
DGAT2 Inhibition Potentiates Lipid Droplet Formation To Reduce Cytotoxicity in APOL1 Kidney Risk VariantsJustin Chun, Cristian V Riella, Hyunjae Chung, et al.
The Journal of Clinical Investigation|December 5, 2002
NPHS2 mutations in late-onset focal segmental glomerulosclerosis: R229Q is a common disease-associated alleleHiroyasu Tsukaguchi, Akulapalli Sudhakar, Tu Cam Le, et al.
Nature Genetics|February 26, 2013
Using population admixture to help complete maps of the human genomeGiulio Genovese, Robert E Handsaker, Heng Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 6, 2018
Interrelated role of Klotho and calcium-sensing receptor in parathyroid hormone synthesis and parathyroid hyperplasiaYi Fan, Weiqing Liu, Ruiye Bi, et al.
Pageof 17

Showing results (121-130 of 167) with videos related to

Sort By:
Pageof 17
Kidney International|June 29, 2016
Mice with mutant Inf2 show impaired podocyte and slit diaphragm integrity in response to protamine-induced kidney injuryBalajikarthick Subramanian, Hua Sun, Paul Yan, et al.
Journal of the American Society of Nephrology : JASN|November 16, 2013
Plasma apolipoprotein L1 levels do not correlate with CKDLeslie A Bruggeman, John F O'Toole, Michael D Ross, et al.
Nature|December 31, 2005
Stem cell engraftment at the endosteal niche is specified by the calcium-sensing receptorGregor B Adams, Karissa T Chabner, Ian R Alley, et al.
Kidney360|September 21, 2022
The KIDNEYCODE Program: Diagnostic Yield and Clinical Features of Individuals with CKDKenneth V Lieberman, Alexander R Chang, Geoffrey A Block, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 25, 2015
APOL1 kidney disease risk variants cause cytotoxicity by depleting cellular potassium and inducing stress-activated protein kinasesOpeyemi A Olabisi, Jia-Yue Zhang, Lynn VerPlank, et al.
Cardiorenal Medicine|June 15, 2017
Apolipoprotein L1 Genetic Variants Are Associated with Chronic Kidney Disease but Not with Cardiovascular Disease in a Population Referred for Cardiac CatheterizationHanghang Wang, Patrick H Pun, Lydia Kwee, et al.
Journal of the American Society of Nephrology : JASN|March 2, 2022
DGAT2 Inhibition Potentiates Lipid Droplet Formation To Reduce Cytotoxicity in APOL1 Kidney Risk VariantsJustin Chun, Cristian V Riella, Hyunjae Chung, et al.
The Journal of Clinical Investigation|December 5, 2002
NPHS2 mutations in late-onset focal segmental glomerulosclerosis: R229Q is a common disease-associated alleleHiroyasu Tsukaguchi, Akulapalli Sudhakar, Tu Cam Le, et al.
Nature Genetics|February 26, 2013
Using population admixture to help complete maps of the human genomeGiulio Genovese, Robert E Handsaker, Heng Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 6, 2018
Interrelated role of Klotho and calcium-sensing receptor in parathyroid hormone synthesis and parathyroid hyperplasiaYi Fan, Weiqing Liu, Ruiye Bi, et al.
Pageof 17